Bacteriocin for new application
AssigneeSyngulon SA
InventorsPhilippe Gabant, Félix Jaumaux
Life of this patent
Estimating the term…
Abstract
Described herein are bacteriocin peptides, peptidomimetics, compositions, pharmaceutical compositions, and cosmetic compositions comprising same. Aspects and embodiments described herein may be used in medical treatment, disinfection of surfaces and cosmetics.
Claims14
A bacteriocin peptide or peptidomimetic, wherein said peptide or peptidomimetic comprises, essentially consists of, or consists of a peptide or peptidomimetic represented by the amino acid sequence of SEQ ID NO:
- 2, or by an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 95%, or 99% identity or similarity with SED ID NO:
- 2, for use in the treatment, prevention and/or delaying of an infection on a subject, preferably a human subject, wherein the infection is:
- a. a skin infection and/or
- b. caused by Staphylococcus aureus.
A bacteriocin peptide or peptidomimetic, wherein said peptide or peptidomimetic comprises, essentially consists of, or consists of a peptide or peptidomimetic represented by the amino acid sequence of any one of SEQ ID NOs:
- 7, 8, 15, 18, 19, 22, 24, 34, 37, 40, 42, 44, 47, 48, or 51.
Dependencies are inferred from the claim text.